Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis | Zendy

Iris Vered | Zendy; Igor Kaiserman | Zendy; BenAmi Sela | Zendy; Joseph Sack | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis

Author(s) -

Iris Vered,

Igor Kaiserman,

BenAmi Sela,

Joseph Sack

Publication year - 1997

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jcem.82.2.3695

Subject(s) - medicine , endocrinology , osteoporosis , bone mineral , testosterone (patch) , estrogen , sex hormone binding globulin , osteopenia , hormone , androgen

Sex hormone deficiency is the most common cause of bone loss. Reduced bone mass and an increased risk for osteoporotic fractures have been described in hypogonadal subjects of both sexes. We present here the results of treating two patients showing abnormal sexual differentiation (an XX male and an XY female), who suffered from bone loss related to sex hormone deficiency, with cross genotype sex hormones.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research